MedWatch

Morgan Stanley: 12 new product launches will pave the way for Ambu

Ambu's many product launches provide beneficial opportunities for Ambu, according to analyst group at investment banking company Morgan Stanley.

Danish Covid-19 therapy shows promise in phase I trial

Union Therapeutics' study with the drug niclosamide for treating Covid-19 patients with kidney diseases shows promising data in a Danish phase I trial program.

FDA investigates infection rates for endoscope use – Olympus and Karl Storz recur in reports

The US FDA gets ready to investigate hundreds of reports on infections following reprocessed endoscopes, sometimes resulting in death. Endoscope manufacturers Olympus and Karl Storz stand out.

CEO after US contract: "For the first time ever, Coloplast has equal access to the market"

Medtech firm Coloplast now has a crucial weapon in its arsenal for realizing the firm's ambitions on the US market.

Analyst on US Coloplast contract: Important contract – volumes will probably increase

It's incredibly important for Coloplast that the medtech company has landed a deal to sell ostomy products by way of the largest group purchasing organization in the US, Vizient, according to senior equity analyst. He expects the new contract will lead to increased volumes in the long term.

Coloplast gets crucial US deal for ostomy product

Danish medtech company Coloplast has landed a contract for ostomy products at Vizient, which is the largest group purchasing organization in the US. It's a three-year deal.